228 related articles for article (PubMed ID: 25502729)
1. Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up.
Sanders ME; Schuyler PA; Simpson JF; Page DL; Dupont WD
Mod Pathol; 2015 May; 28(5):662-9. PubMed ID: 25502729
[TBL] [Abstract][Full Text] [Related]
2. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Sanders ME; Schuyler PA; Dupont WD; Page DL
Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
[TBL] [Abstract][Full Text] [Related]
3. Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center.
Farshid G; Edwards S; Kollias J; Gill PG
Mod Pathol; 2018 Mar; 31(3):395-405. PubMed ID: 29099502
[TBL] [Abstract][Full Text] [Related]
4. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
[TBL] [Abstract][Full Text] [Related]
5. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.
Page DL; Dupont WD; Rogers LW; Jensen RA; Schuyler PA
Cancer; 1995 Oct; 76(7):1197-200. PubMed ID: 8630897
[TBL] [Abstract][Full Text] [Related]
6. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.
Van Bockstal MR; Agahozo MC; Koppert LB; van Deurzen CHM
Int J Cancer; 2020 Mar; 146(5):1189-1197. PubMed ID: 31018242
[TBL] [Abstract][Full Text] [Related]
7. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
[TBL] [Abstract][Full Text] [Related]
8. Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
Curigliano G; Disalvatore D; Esposito A; Pruneri G; Lazzeroni M; Guerrieri-Gonzaga A; Luini A; Orecchia R; Goldhirsch A; Rotmensz N; Bonanni B; Viale G
Ann Oncol; 2015 Apr; 26(4):682-687. PubMed ID: 25600567
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome for mammographically detected ductal carcinoma in situ managed with breast conservation treatment: prognostic significance of reexcision.
Vapiwala N; Harris E; Hwang WT; Solin LJ
Cancer J; 2006; 12(1):25-32. PubMed ID: 16613659
[TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.
Solin LJ; Yeh IT; Kurtz J; Fourquet A; Recht A; Kuske R; McCormick B; Cross MA; Schultz DJ; Amalric R
Cancer; 1993 Apr; 71(8):2532-42. PubMed ID: 8384070
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.
van Maaren MC; Lagendijk M; Tilanus-Linthorst MMA; de Munck L; Pijnappel RM; Schmidt MK; Wesseling J; Koppert LB; Siesling S
Eur J Cancer; 2018 Sep; 101():134-142. PubMed ID: 30059817
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes of Multiple-Wire Localizations for More Extensive Breast Cancer: Multiple-Wire Excision Does Not Increase Recurrence, Unplanned Imaging, or Biopsies.
Brown CL; McEvoy MP; Smith BL; Lanahan CR; Kelly BN; Coopey SB; Hughes KS; Oseni TS; McGugin C; Wong SM; Gadd MA; Specht MC
Clin Breast Cancer; 2020 Jun; 20(3):215-219. PubMed ID: 31859233
[TBL] [Abstract][Full Text] [Related]
14. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
[TBL] [Abstract][Full Text] [Related]
15. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.
Subhedar P; Olcese C; Patil S; Morrow M; Van Zee KJ
Ann Surg Oncol; 2015 Oct; 22(10):3273-81. PubMed ID: 26215193
[TBL] [Abstract][Full Text] [Related]
16. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
17. Breast conservation therapy utilizing partial breast brachytherapy for early-stage cancer of the breast: a retrospective review from the Saint Luke's Cancer Institute.
Edwards JM; Herzberg SM; Shook JW; Beirne TK; Schomas DA
Am J Clin Oncol; 2015 Apr; 38(2):174-8. PubMed ID: 23608831
[TBL] [Abstract][Full Text] [Related]
18. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
[TBL] [Abstract][Full Text] [Related]
20. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
